SE465951B - Isomer av inositoltrifosfat foeretraedesvis i saltform foer anvaendning som terapeutiskt eller profylaktiskt medel samt kompositioner daerav - Google Patents

Isomer av inositoltrifosfat foeretraedesvis i saltform foer anvaendning som terapeutiskt eller profylaktiskt medel samt kompositioner daerav

Info

Publication number
SE465951B
SE465951B SE8405295A SE8405295A SE465951B SE 465951 B SE465951 B SE 465951B SE 8405295 A SE8405295 A SE 8405295A SE 8405295 A SE8405295 A SE 8405295A SE 465951 B SE465951 B SE 465951B
Authority
SE
Sweden
Prior art keywords
inositol
isomer
triphosphate
myo
ions
Prior art date
Application number
SE8405295A
Other languages
English (en)
Swedish (sv)
Other versions
SE8405295D0 (sv
SE8405295L (sv
Inventor
M Siren
Original Assignee
Perstorp Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Perstorp Ab filed Critical Perstorp Ab
Priority to SE8405295A priority Critical patent/SE465951B/sv
Publication of SE8405295D0 publication Critical patent/SE8405295D0/xx
Priority to SE8503164A priority patent/SE8503164L/xx
Priority to SE8503165A priority patent/SE8503165L/xx
Priority to NZ213855A priority patent/NZ213855A/xx
Priority to US06/788,830 priority patent/US4735902A/en
Priority to US06/788,801 priority patent/US4735936A/en
Priority to US06/788,829 priority patent/US4777134A/en
Priority to US06/788,823 priority patent/US4734283A/en
Priority to JP60234666A priority patent/JPS61171491A/ja
Priority to SE8504967A priority patent/SE8504967L/xx
Priority to AU48930/85A priority patent/AU589378B2/en
Priority to EP85113382A priority patent/EP0179440B1/en
Priority to NO854213A priority patent/NO168227C/no
Priority to ZA858107A priority patent/ZA858107B/xx
Priority to ZA858106A priority patent/ZA858106B/xx
Priority to DE19853537563 priority patent/DE3537563A1/de
Priority to FI854128A priority patent/FI88855C/fi
Priority to AU48933/85A priority patent/AU598727B2/en
Priority to AT85113384T priority patent/ATE60774T1/de
Priority to DE8585113384T priority patent/DE3581691D1/de
Priority to AT85113381T priority patent/ATE37788T1/de
Priority to DE8585113381T priority patent/DE3565464D1/de
Priority to DE8585113382T priority patent/DE3577851D1/de
Priority to FR8515676A priority patent/FR2573080B1/fr
Priority to SE8504969A priority patent/SE8504969L/xx
Priority to IT22574/85A priority patent/IT1190403B/it
Priority to EP85113384A priority patent/EP0179442B1/en
Priority to HU854074A priority patent/HU196077B/hu
Priority to FR8515675A priority patent/FR2571967B1/fr
Priority to IT22573/85A priority patent/IT1190402B/it
Priority to SE8504970A priority patent/SE458121B/sv
Priority to SE8504968A priority patent/SE465164B/sv
Priority to ZA858105A priority patent/ZA858105B/xx
Priority to JP60234668A priority patent/JPS61171789A/ja
Priority to FI854126A priority patent/FI85490C/fi
Priority to EP85113381A priority patent/EP0179439B1/en
Priority to AU48931/85A priority patent/AU582594B2/en
Priority to DE8585113383T priority patent/DE3569188D1/de
Priority to CH4537/85A priority patent/CH668597A5/fr
Priority to DK483485A priority patent/DK483485A/da
Priority to AU48932/85A priority patent/AU596080B2/en
Priority to DK198504833A priority patent/DK172857B1/da
Priority to DE19853537542 priority patent/DE3537542A1/de
Priority to CA000493572A priority patent/CA1337338C/en
Priority to GB08526079A priority patent/GB2169602B/en
Priority to AT85113382T priority patent/ATE53038T1/de
Priority to BE0/215762A priority patent/BE903497A/fr
Priority to DE19853537550 priority patent/DE3537550A1/de
Priority to JP60234667A priority patent/JPS61181347A/ja
Priority to ZA858108A priority patent/ZA858108B/xx
Priority to AT85113383T priority patent/ATE41853T1/de
Priority to CH4536/85A priority patent/CH666812A5/fr
Priority to DK198504832A priority patent/DK172852B1/da
Priority to IL76777A priority patent/IL76777A/xx
Priority to NO854211A priority patent/NO854211L/no
Priority to FI854127A priority patent/FI82474C/fi
Priority to GB08526078A priority patent/GB2167298B/en
Priority to CN 85109110 priority patent/CN1006401B/zh
Priority to EP85113383A priority patent/EP0179441B1/en
Priority to BE0/215763A priority patent/BE903498A/fr
Priority to DE19853537569 priority patent/DE3537569A1/de
Priority to NO854212A priority patent/NO169010C/no
Priority to GB08526081A priority patent/GB2167420B/en
Priority to GB8526080A priority patent/GB2167283B/en
Priority to JP60234665A priority patent/JPS61171422A/ja
Publication of SE8405295L publication Critical patent/SE8405295L/xx
Priority to US07/015,679 priority patent/US4797390A/en
Priority to US07/015,698 priority patent/US4793945A/en
Priority to US07/015,699 priority patent/US4851560A/en
Priority to US07/015,676 priority patent/US4794014A/en
Priority to US07/214,500 priority patent/US5003098A/en
Priority to US07/251,566 priority patent/US5023248A/en
Priority to US07/367,968 priority patent/US5051411A/en
Priority to US07/580,661 priority patent/US5128332A/en
Publication of SE465951B publication Critical patent/SE465951B/sv
Priority to US07/900,129 priority patent/US5330979A/en
Priority to US08/160,555 priority patent/US5407924A/en
Priority to US08/343,239 priority patent/US5545632A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/117—Esters of phosphoric acids with cycloaliphatic alcohols
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
    • A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
    • A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
    • A21D2/30—Organic phosphorus compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23B—PRESERVING, e.g. BY CANNING, MEAT, FISH, EGGS, FRUIT, VEGETABLES, EDIBLE SEEDS; CHEMICAL RIPENING OF FRUIT OR VEGETABLES; THE PRESERVED, RIPENED, OR CANNED PRODUCTS
    • A23B7/00—Preservation or chemical ripening of fruit or vegetables
    • A23B7/14—Preserving or ripening with chemicals not covered by groups A23B7/08 or A23B7/10
    • A23B7/153—Preserving or ripening with chemicals not covered by groups A23B7/08 or A23B7/10 in the form of liquids or solids
    • A23B7/154—Organic compounds; Microorganisms; Enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/03—Organic compounds
    • A23L29/05—Organic compounds containing phosphorus as heteroatom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
    • A23L3/34—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
    • A23L3/3454—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
    • A23L3/3463—Organic compounds; Microorganisms; Enzymes
    • A23L3/3553—Organic compounds containing phosphorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P9/00—Preparation of organic compounds containing a metal or atom other than H, N, C, O, S or halogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Polymers & Plastics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
SE8405295A 1984-10-23 1984-10-23 Isomer av inositoltrifosfat foeretraedesvis i saltform foer anvaendning som terapeutiskt eller profylaktiskt medel samt kompositioner daerav SE465951B (sv)

Priority Applications (76)

Application Number Priority Date Filing Date Title
SE8405295A SE465951B (sv) 1984-10-23 1984-10-23 Isomer av inositoltrifosfat foeretraedesvis i saltform foer anvaendning som terapeutiskt eller profylaktiskt medel samt kompositioner daerav
SE8503164A SE8503164L (sv) 1984-10-23 1985-06-26 Stabilisator
SE8503165A SE8503165L (sv) 1984-10-23 1985-06-26 Stabilisator ii
NZ213855A NZ213855A (en) 1984-10-23 1985-10-16 Pharmaceutical compositons containing inositol triphosphate
US06/788,830 US4735902A (en) 1984-10-23 1985-10-18 Stabilized composition containing inositoltriphosphate
US06/788,801 US4735936A (en) 1984-10-23 1985-10-18 Pharmaceutical composition containing inositol triphosphate
US06/788,829 US4777134A (en) 1984-10-23 1985-10-18 Inositoltriphosphate
US06/788,823 US4734283A (en) 1984-10-23 1985-10-18 Method of making a food composition containing inosotoltriphosphate and the composition
JP60234666A JPS61171491A (ja) 1984-10-23 1985-10-22 イノシト−ルトリホスフエ−ト及びその製造方法
SE8504967A SE8504967L (sv) 1984-10-23 1985-10-22 Farmaceutisk komposition och forfarande for behandling av kroppen
AU48930/85A AU589378B2 (en) 1984-10-23 1985-10-22 Pharmaceutical compositions containing inositol triphosphates
EP85113382A EP0179440B1 (en) 1984-10-23 1985-10-22 Inositoltriphosphate, a method for preparing same and a composition containing same
NO854213A NO168227C (no) 1984-10-23 1985-10-22 Analogifremgangsmaate til fremstilling av et naeringsmiddelfra en naeringsmiddelblanding.
ZA858107A ZA858107B (en) 1984-10-23 1985-10-22 A method of making a food composition containing inositoltriphosphate and the composition
ZA858106A ZA858106B (en) 1984-10-23 1985-10-22 Inositoltriphosphate
DE19853537563 DE3537563A1 (de) 1984-10-23 1985-10-22 Stabilisierte zusammensetzung mit einem gehalt an inositoltriphosphat und verfahren zu deren herstellung
FI854128A FI88855C (fi) 1984-10-23 1985-10-22 Foerfarande foer framstaellning av en livsmedelskomposition som innehaoller inositoltrifosfat
AU48933/85A AU598727B2 (en) 1984-10-23 1985-10-22 Stabilized composition containing inositoltriphosphate
AT85113384T ATE60774T1 (de) 1984-10-23 1985-10-22 Inositoltriphosphat enthaltende stabilisierte zusammensetzung und verfahren zur stabilisierung der zusammensetzung.
DE8585113384T DE3581691D1 (de) 1984-10-23 1985-10-22 Inositoltriphosphat enthaltende stabilisierte zusammensetzung und verfahren zur stabilisierung der zusammensetzung.
AT85113381T ATE37788T1 (de) 1984-10-23 1985-10-22 Arzneimittel und verfahren zu ihrer herstellung.
DE8585113381T DE3565464D1 (en) 1984-10-23 1985-10-22 A pharmaceutical composition and a method for preparing same
DE8585113382T DE3577851D1 (de) 1984-10-23 1985-10-22 Inositoltriphosphat, verfahren zu seiner herstellung und dieses enthaltende zubereitung.
FR8515676A FR2573080B1 (fr) 1984-10-23 1985-10-22 Inositol-triphosphate
SE8504969A SE8504969L (sv) 1984-10-23 1985-10-22 Forfarande for framstellning av en livsmedelskomposition innehallande inositoltrifosfat och kompositionen
IT22574/85A IT1190403B (it) 1984-10-23 1985-10-22 Composizione farmaceutica e procedimento per trattare il corpo umano con essa
EP85113384A EP0179442B1 (en) 1984-10-23 1985-10-22 Stabilized composition containing inositoltriphosphate and method for stabilizing the composition
HU854074A HU196077B (en) 1984-10-23 1985-10-22 Process for producing inosite-triphosphates and pharmaceutical preparations containing such compounds
FR8515675A FR2571967B1 (fr) 1984-10-23 1985-10-22 Composition pharmaceutique et procede de traitement du corps.
IT22573/85A IT1190402B (it) 1984-10-23 1985-10-22 Inositol-trifosfato
SE8504970A SE458121B (sv) 1984-10-23 1985-10-22 Stabiliserad komposition samt foerfarande foer stabilisering
SE8504968A SE465164B (sv) 1984-10-23 1985-10-22 Inositoltrifosfat, ett foerfarande foer framstaellning daerav och en komposition innehaallande detta
ZA858105A ZA858105B (en) 1984-10-23 1985-10-22 A pharmaceutical composition and a method of treating the body
JP60234668A JPS61171789A (ja) 1984-10-23 1985-10-22 イノシト−ルトリホスフエ−ト含有安定化組成物
FI854126A FI85490C (fi) 1984-10-23 1985-10-22 Foerfarande foer framstaellning av terapeutiskt anvaendbara inositoltrifosfat.
EP85113381A EP0179439B1 (en) 1984-10-23 1985-10-22 A pharmaceutical composition and a method for preparing same
AU48931/85A AU582594B2 (en) 1984-10-23 1985-10-22 Inositoltriphosphate
DE8585113383T DE3569188D1 (en) 1984-10-23 1985-10-22 A method of making a food composition containing inositoltriphosphate and the composition
CH4537/85A CH668597A5 (fr) 1984-10-23 1985-10-22 Procede de fabrication d'une composition alimentaire comprenant de l'inositoltriphosphate et la composition alimentaire.
DK483485A DK483485A (da) 1984-10-23 1985-10-22 Stabiliseret praeparat indeholdende inositoltriphosphat
AU48932/85A AU596080B2 (en) 1984-10-23 1985-10-22 A method of making a food composition containing inositoltriphosphate and the composition
DK198504833A DK172857B1 (da) 1984-10-23 1985-10-22 Inositoltriphosphat-forbindelse, fremgangsmåde til dens fremstilling samt vandig opløsning og sammensætning med indhold der
DE19853537542 DE3537542A1 (de) 1984-10-23 1985-10-22 Nahrungsmittelzusammensetzung mit einem gehalt an inositoltriphosphat und verfahren zu deren herstellung
CA000493572A CA1337338C (en) 1984-10-23 1985-10-22 Inositoltriphosphate
GB08526079A GB2169602B (en) 1984-10-23 1985-10-22 Inositol triphosphate
AT85113382T ATE53038T1 (de) 1984-10-23 1985-10-22 Inositoltriphosphat, verfahren zu seiner herstellung und dieses enthaltende zubereitung.
BE0/215762A BE903497A (fr) 1984-10-23 1985-10-22 Composition pharmaceutique
DE19853537550 DE3537550A1 (de) 1984-10-23 1985-10-22 Pharmazeutische zusammensetzung
JP60234667A JPS61181347A (ja) 1984-10-23 1985-10-22 イノシト−ルトリホスフエ−ト含有食品及びその製造方法
ZA858108A ZA858108B (en) 1984-10-23 1985-10-22 Stabilized composition containing inositoltriphosphate
AT85113383T ATE41853T1 (de) 1984-10-23 1985-10-22 Verfahren zur herstellung eines inositoltriphosphat enthaltenden nahrungsmittels und die hergestellte zusammensetzung.
CH4536/85A CH666812A5 (fr) 1984-10-23 1985-10-22 Composition pharmaceutique contenant de l'inositol triphosphate.
DK198504832A DK172852B1 (da) 1984-10-23 1985-10-22 Farmaceutisk præparat og anvendelse af inositoltriphosphat (IP3) til fremstilling deraf
IL76777A IL76777A (en) 1984-10-23 1985-10-22 Inositoltriphosphates,their preparation and pharmaceutical compositions containing them
NO854211A NO854211L (no) 1984-10-23 1985-10-22 Farmasoeytisk blanding og fremgangsmaate til behandling av legemet.
FI854127A FI82474C (fi) 1984-10-23 1985-10-22 Inositoltrifosfat och foerfarande foer dess produktion.
GB08526078A GB2167298B (en) 1984-10-23 1985-10-22 Pharmaceutical compositions containing inositol triphosphate
CN 85109110 CN1006401B (zh) 1984-10-23 1985-10-22 肌醇三磷酸的制备方法
EP85113383A EP0179441B1 (en) 1984-10-23 1985-10-22 a method of making a food composition containing inositoltriphosphate and the composition
BE0/215763A BE903498A (fr) 1984-10-23 1985-10-22 Inositol-triphosphate
DE19853537569 DE3537569A1 (de) 1984-10-23 1985-10-22 Inositoltriphosphate, verfahren zu deren herstellung und zusammensetzungen, welche diese enthalten
NO854212A NO169010C (no) 1984-10-23 1985-10-22 Inositoltrifosfat
GB08526081A GB2167420B (en) 1984-10-23 1985-10-22 Improvements in or relating to a stabilized compositions containing inositoltriphosphate
GB8526080A GB2167283B (en) 1984-10-23 1985-10-22 Improvements in or relating to a method of making an improved food composition.
JP60234665A JPS61171422A (ja) 1984-10-23 1985-10-22 医薬組成物
US07/015,679 US4797390A (en) 1984-10-23 1987-02-17 Inositol triphosphate pharmaceutical compositions
US07/015,698 US4793945A (en) 1984-10-23 1987-02-17 Use of inositol triphosphate as a stabilizer and compositions formed therefrom
US07/015,699 US4851560A (en) 1984-10-23 1987-02-17 Inositol triphosphates
US07/015,676 US4794014A (en) 1984-10-23 1987-02-17 Food compositions containing inositol triphosphate and method for making same
US07/214,500 US5003098A (en) 1984-10-23 1988-07-01 Method of reducing or eliminating adverse effects of a pharmaceutical composition or a drug
US07/251,566 US5023248A (en) 1984-10-23 1988-09-30 Method of treating diabetes with inositol triphosphate
US07/367,968 US5051411A (en) 1984-10-23 1989-06-19 A method of achieving an immunosuppressive effect
US07/580,661 US5128332A (en) 1984-10-23 1990-09-11 Method of treating cardiovascular diseases using inositoltrisphosphate
US07/900,129 US5330979A (en) 1984-10-23 1992-06-18 Method of treating renal disorders with inositoltriphosphate
US08/160,555 US5407924A (en) 1984-10-23 1993-12-01 Method of treating pain using inositol triphosphate
US08/343,239 US5545632A (en) 1984-10-23 1994-11-22 Method of treating retroviral disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8405295A SE465951B (sv) 1984-10-23 1984-10-23 Isomer av inositoltrifosfat foeretraedesvis i saltform foer anvaendning som terapeutiskt eller profylaktiskt medel samt kompositioner daerav

Publications (3)

Publication Number Publication Date
SE8405295D0 SE8405295D0 (sv) 1984-10-23
SE8405295L SE8405295L (sv) 1986-04-24
SE465951B true SE465951B (sv) 1991-11-25

Family

ID=20357457

Family Applications (6)

Application Number Title Priority Date Filing Date
SE8405295A SE465951B (sv) 1984-10-23 1984-10-23 Isomer av inositoltrifosfat foeretraedesvis i saltform foer anvaendning som terapeutiskt eller profylaktiskt medel samt kompositioner daerav
SE8503165A SE8503165L (sv) 1984-10-23 1985-06-26 Stabilisator ii
SE8503164A SE8503164L (sv) 1984-10-23 1985-06-26 Stabilisator
SE8504968A SE465164B (sv) 1984-10-23 1985-10-22 Inositoltrifosfat, ett foerfarande foer framstaellning daerav och en komposition innehaallande detta
SE8504967A SE8504967L (sv) 1984-10-23 1985-10-22 Farmaceutisk komposition och forfarande for behandling av kroppen
SE8504969A SE8504969L (sv) 1984-10-23 1985-10-22 Forfarande for framstellning av en livsmedelskomposition innehallande inositoltrifosfat och kompositionen

Family Applications After (5)

Application Number Title Priority Date Filing Date
SE8503165A SE8503165L (sv) 1984-10-23 1985-06-26 Stabilisator ii
SE8503164A SE8503164L (sv) 1984-10-23 1985-06-26 Stabilisator
SE8504968A SE465164B (sv) 1984-10-23 1985-10-22 Inositoltrifosfat, ett foerfarande foer framstaellning daerav och en komposition innehaallande detta
SE8504967A SE8504967L (sv) 1984-10-23 1985-10-22 Farmaceutisk komposition och forfarande for behandling av kroppen
SE8504969A SE8504969L (sv) 1984-10-23 1985-10-22 Forfarande for framstellning av en livsmedelskomposition innehallande inositoltrifosfat och kompositionen

Country Status (19)

Country Link
US (7) US4734283A (ja)
EP (3) EP0179440B1 (ja)
JP (4) JPS61171491A (ja)
AT (3) ATE37788T1 (ja)
AU (3) AU589378B2 (ja)
BE (2) BE903498A (ja)
CH (2) CH668597A5 (ja)
DE (6) DE3537542A1 (ja)
DK (2) DK172857B1 (ja)
FI (3) FI82474C (ja)
FR (2) FR2573080B1 (ja)
GB (3) GB2167298B (ja)
HU (1) HU196077B (ja)
IL (1) IL76777A (ja)
IT (2) IT1190403B (ja)
NO (3) NO854211L (ja)
NZ (1) NZ213855A (ja)
SE (6) SE465951B (ja)
ZA (4) ZA858105B (ja)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5095035A (en) * 1981-07-31 1992-03-10 Eby Iii George A Flavor stable zinc acetate compositions for oral absorption
SE465951B (sv) 1984-10-23 1991-11-25 Perstorp Ab Isomer av inositoltrifosfat foeretraedesvis i saltform foer anvaendning som terapeutiskt eller profylaktiskt medel samt kompositioner daerav
US4735902A (en) * 1984-10-23 1988-04-05 Matti Siren Stabilized composition containing inositoltriphosphate
US5128332A (en) * 1984-10-23 1992-07-07 Perstorp Ab Method of treating cardiovascular diseases using inositoltrisphosphate
US5407924A (en) * 1984-10-23 1995-04-18 Perstorp Ab Method of treating pain using inositol triphosphate
SE465305B (sv) * 1986-04-16 1991-08-26 Perstorp Ab Anvaendning av inositolfosfat foer framstaellning av ett laekemedel
US5330979A (en) * 1984-10-23 1994-07-19 Perstorp Ab Method of treating renal disorders with inositoltriphosphate
JPS63198642A (ja) * 1986-03-11 1988-08-17 Mitsui Toatsu Chem Inc ミオイノシトール誘導体の製造方法
DE3783694T2 (de) * 1986-03-11 1993-05-19 Mitsui Toatsu Chemicals Verfahren zur herstellung von myoinositolabkoemmlingen.
US5057507A (en) * 1986-04-16 1991-10-15 Perstorp Ab Method of alleviating bone damage with inositoltriphosphate
EP0438386A4 (en) * 1986-11-05 1991-09-11 George Weston Foods Limited Novel improvers for flour and yeast raised baked goods
US5274161A (en) * 1986-11-26 1993-12-28 Perstorp Ab Derivatives of cyclohexane
SE8605063D0 (sv) * 1986-11-26 1986-11-26 Matti Siren Derivatives of cyclohexane
GB8705811D0 (en) * 1987-03-11 1987-04-15 Research Corp Ltd Inositol derivatives
JP2597618B2 (ja) * 1987-12-28 1997-04-09 三井東圧化学 株式会社 光学分割方法
JPH01287035A (ja) * 1988-05-13 1989-11-17 Sanwa Kagaku Kenkyusho Co Ltd 薬物並びにアルコール性中毒の予防剤とその治療剤
JPH01294631A (ja) * 1988-05-19 1989-11-28 Sanwa Kagaku Kenkyusho Co Ltd 糖尿性疾患治療予防剤及び飲食、し好物
SE464059C (sv) * 1988-09-15 1997-06-02 Perstorp Ab Användning av inositoltrifosfat för framställning av läkemedel
US5366736A (en) * 1989-02-16 1994-11-22 University Of Georgia Research Foundation, Inc. Vitamin D derivative feed compositions and methods of use
US5316770A (en) * 1989-02-16 1994-05-31 University Of Georgia Research Foundation, Inc. Vitamin D derivative feed compositions and methods of use
JPH04504847A (ja) * 1989-03-08 1992-08-27 ザ　ユニバーシティ　オヴ　バージニア　パテント　ファウンデーション インスリン抵抗性糖尿病のための食事用補添物
US5428066A (en) * 1989-03-08 1995-06-27 Larner; Joseph Method of reducing elevated blood sugar in humans
US5427956A (en) * 1989-03-08 1995-06-27 The University Of Virginia Patent Foundation Quantitative analysis for diabetic condition predictor
US5750348A (en) * 1989-03-08 1998-05-12 The University Of Virginia Patents Foundation Method for detecting insulin resistance
SE8902766D0 (sv) * 1989-08-17 1989-08-17 Siren Matti Saett att oeka den farmaceutiska effekten av inositolfosfat samt en beredning med foerbaettrad farmaceutisk effekt
SE8904355D0 (sv) * 1989-12-21 1989-12-21 Perstorp Ab Medicament
US5593963A (en) * 1990-09-21 1997-01-14 Mogen International Expression of phytase in plants
KR100225087B1 (ko) * 1990-03-23 1999-10-15 한스 발터라벤 피타아제의 식물내 발현
US7033627B2 (en) 1990-03-23 2006-04-25 Syngenta Mogen B.V. Production of enzymes in seeds and their use
US5543576A (en) * 1990-03-23 1996-08-06 Mogen International Production of enzymes in seeds and their use
SE9002278L (sv) * 1990-06-28 1991-12-29 Perstorp Ab Anvaendning av inositoltrisfosfat foer framstaellning av ett laekemedel
US6007809A (en) * 1990-08-29 1999-12-28 Chaykin; Sterling Method and product for eliminating undesirable side effects of eating vegetables such as onion or garlic
KR930702013A (ko) * 1990-08-29 1993-09-08 차이킨 스터얼링 양파 또는 마늘과 같은 채소류를 섭취하는 데에 있어서 바람직하지 않은 부작용을 제거하기 위한 방법 및 생성물
US5514398A (en) * 1990-11-05 1996-05-07 Amano Pharmaceutical Co., Ltd. Food additive and use thereof
SE9102068L (sv) * 1991-07-03 1993-01-04 Perstorp Ab Derivat av inositol, kompositioner innehaallande dessa samt anvaendning daerav
SE469260B (sv) * 1992-02-25 1993-06-14 Perstorp Ab En farmaceutisk komposition med foerbaettrad biotillgaenglighet avseende inositolfosfat
US5292537A (en) * 1992-11-12 1994-03-08 Bran Tec, Inc. Method for stabilizing rice bran and rice bran products
JP2696057B2 (ja) * 1993-05-11 1998-01-14 ニチモウ株式会社 穀類を原料とした生成物の製造方法
US5827837A (en) * 1993-08-20 1998-10-27 The Regents Of The University Of California Polyanion anti-inflammatory agents
SE503122C2 (sv) * 1993-11-22 1996-03-25 Perstorp Ab Användning av en inositoltrisfosfatester för behandling av inflammatoriska tillstånd
SE502989C2 (sv) * 1993-11-22 1996-03-04 Perstorp Ab Användning av en inositoltrisfosfatester för beredning av läkemedel
US5466465A (en) * 1993-12-30 1995-11-14 Harrogate Holdings, Limited Transdermal drug delivery system
SE502574C2 (sv) * 1994-01-25 1995-11-13 Perstorp Ab En farmaceutisk komposition med förbättrad biotillgänglighet hos inositolfosfat
US6451572B1 (en) 1998-06-25 2002-09-17 Cornell Research Foundation, Inc. Overexpression of phytase genes in yeast systems
ES2248067T3 (es) 1999-03-31 2006-03-16 Cornell Research Foundation, Inc. Fosfatasas con actividad de fitasa mejorada.
US6841370B1 (en) 1999-11-18 2005-01-11 Cornell Research Foundation, Inc. Site-directed mutagenesis of Escherichia coli phytase
US6383817B2 (en) 1999-12-30 2002-05-07 Wake Forest University Cadmium is a risk factor for human pancreatic cancer
US20020193379A1 (en) * 2001-06-05 2002-12-19 Insmed Incorporated Compositions and methods for decreasing the risk of or preventing neural tube disorders in mammals
FR2828206B1 (fr) * 2001-08-03 2004-09-24 Centre Nat Rech Scient Utilisation d'inhibiteurs des lysyl oxydases pour la culture cellulaire et le genie tissulaire
AU2002356880A1 (en) 2001-10-31 2003-05-12 Phytex, Llc Phytase-containing animal food and method
US20050108780A1 (en) * 2002-01-24 2005-05-19 Erasmus University Intracellular antibodies for a retrovirus protein
US7084115B2 (en) 2002-04-29 2006-08-01 Oxyplus, Inc. Inositol pyrophosphates, and methods of use thereof
CA2498017C (en) * 2002-09-13 2016-06-14 Cornell Research Foundation, Inc. Using mutations to improve aspergillus phytases
CA2413240A1 (en) * 2002-11-29 2004-05-29 Mcn Bioproducts Inc. Purification of inositol from plant materials
US20050123644A1 (en) * 2003-01-24 2005-06-09 Cargill, Incorporated Phosphate-containing fertilizer derived from steepwater
US7521481B2 (en) 2003-02-27 2009-04-21 Mclaurin Joanne Methods of preventing, treating and diagnosing disorders of protein aggregation
US20050048165A1 (en) * 2003-03-31 2005-03-03 Sadanandan Bindu Process for the preparation of Chapathi dough with reduced phytic acid level
US7745423B2 (en) * 2004-07-06 2010-06-29 NormOxys, Inc Calcium/sodium salt of inositol tripyrophosphate as an allosteric effector of hemoglobin
US20060258626A1 (en) * 2004-07-06 2006-11-16 Claude Nicolau Use of inositol-tripyrophosphate in treating tumors and diseases
US20070135389A1 (en) * 2004-07-06 2007-06-14 Claude Nicolau Tumor eradication by inositol-tripyrophosphate
US20060106000A1 (en) * 2004-07-06 2006-05-18 Claude Nicolau Use of inositol-tripyrophosphate in treating tumors and diseases
JP5028405B2 (ja) * 2005-03-18 2012-09-19 ノームオクシス インコーポレイテッド ヘモグロビンのアロステリックエフェクターとしてのミオイノシトール１，６：２，３：４，５トリピロリン酸のカルシウム塩
US7919297B2 (en) 2006-02-21 2011-04-05 Cornell Research Foundation, Inc. Mutants of Aspergillus niger PhyA phytase and Aspergillus fumigatus phytase
US20070212449A1 (en) * 2006-03-02 2007-09-13 Shamsuddin Abulkalam M Reduction of the titratable acidity and the prevention of tooth and other bone degeneration
WO2008017066A2 (en) * 2006-08-03 2008-02-07 Cornell Research Foundation, Inc. Phytases with improved thermal stability
US20110218176A1 (en) 2006-11-01 2011-09-08 Barbara Brooke Jennings-Spring Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development
US20090214474A1 (en) * 2006-11-01 2009-08-27 Barbara Brooke Jennings Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development
US20080103116A1 (en) * 2006-11-01 2008-05-01 Jennings-Spring Barbara L Method of treatment and compositions of D-chiro inositol and phosphates thereof
AU2008246061A1 (en) * 2007-05-01 2008-11-06 Normoxys, Inc. Erythropoietin complementation or replacement
US8192734B2 (en) 2007-07-09 2012-06-05 Cornell University Compositions and methods for bone strengthening
CA2699854A1 (en) * 2007-09-17 2009-03-26 Bioneris Ab Use of compounds comprising phosphorous for the treatment of cachexia
ES2604110T3 (es) * 2011-07-01 2017-03-03 Shiseido Company, Ltd. Activador de la producción del factor de crecimiento derivado de plaquetas-BB, y activador de la producción de células madre mesenquimatosas, estabilizador de células madre y regenerador de la dermis comprendiendo cada uno el mismo
FR3017134B1 (fr) * 2014-02-06 2018-04-20 Lesaffre Et Compagnie Levure biologique, procede d'obtention et utilisations

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2723938A (en) * 1952-12-05 1955-11-15 Bristol Lab Inc Aqueous penicillin suspensions comprising inositol phosphoric acids and their salts
US3591665A (en) * 1967-09-08 1971-07-06 Mitsui Toatsu Chemicals Process for producing phytic acid
FI51469C (fi) * 1968-01-10 1977-01-10 Morinaga Milk Industry Co Ltd Menetelmä radioaktiivisen strontium 90 saasteen poistamiseksi nestemäi sistä elintarvikkeista tai vedestä.
JPS50111246A (ja) * 1974-02-14 1975-09-01
US4154824A (en) * 1976-07-20 1979-05-15 Interx Research Corporation Nonbitter tasting potassium product for oral administration to warm-blooded animals and method for preparing same
JPS53124636A (en) * 1977-04-04 1978-10-31 Kisaku Mori Method of increasing meranine contained in animal and plant
DE2740053A1 (de) * 1977-09-06 1979-05-03 Klaus Prof Dr Med Gersonde Verwendung von allosterischen effektoren mit hilfe von lipidvesikeln ueber eine irreversible inkorporierung zwecks verbesserter o tief 2 -entladung des haemoglobins in erythrozyten
JPS5486666A (en) * 1977-12-22 1979-07-10 Ajinomoto Kk Cola beverage
JPS5798292A (en) * 1980-12-09 1982-06-18 Jiyaade:Kk Powdery phytic acid and its preparation
JPS58198254A (ja) * 1982-05-14 1983-11-18 Kyowa Hakko Kogyo Co Ltd 加工食品の品質改良法
SE450325B (sv) * 1983-02-23 1987-06-22 Tricum Ab Kostfiberprodukt baserad pa skaldelar fran froet hos ceralier
SE465951B (sv) * 1984-10-23 1991-11-25 Perstorp Ab Isomer av inositoltrifosfat foeretraedesvis i saltform foer anvaendning som terapeutiskt eller profylaktiskt medel samt kompositioner daerav
US4735902A (en) * 1984-10-23 1988-04-05 Matti Siren Stabilized composition containing inositoltriphosphate
AU2001248278A1 (en) 2000-04-13 2001-10-30 Novozymes A/S Extracellular expression of pectate lyase using bacillus or escherichia coli

Also Published As

Publication number Publication date
JPS61171789A (ja) 1986-08-02
SE8504968D0 (sv) 1985-10-22
GB8526079D0 (en) 1985-11-27
JPH0338824B2 (ja) 1991-06-11
FI85490C (fi) 1992-04-27
SE8504968L (sv) 1986-04-24
AU4893285A (en) 1986-05-01
EP0179440A1 (en) 1986-04-30
GB2167283A (en) 1986-05-29
IL76777A (en) 1990-09-17
FI854126L (fi) 1986-04-24
FR2571967A1 (fr) 1986-04-25
SE8503164L (sv) 1986-04-24
JPH0354924B2 (ja) 1991-08-21
AU4893185A (en) 1986-05-01
IT8522573A0 (it) 1985-10-22
US4794014A (en) 1988-12-27
ZA858105B (en) 1986-06-25
FI854128A0 (fi) 1985-10-22
ZA858108B (en) 1986-06-25
SE465164B (sv) 1991-08-05
NO168227B (no) 1991-10-21
US5003098A (en) 1991-03-26
DK483385A (da) 1986-04-24
SE8504967L (sv) 1986-04-24
SE8504969D0 (sv) 1985-10-22
FI854128L (fi) 1986-04-24
JPS61181347A (ja) 1986-08-14
NO854211L (no) 1986-04-24
ZA858106B (en) 1986-06-25
US4851560A (en) 1989-07-25
CH668597A5 (fr) 1989-01-13
EP0179441A2 (en) 1986-04-30
GB8526080D0 (en) 1985-11-27
FI82474C (fi) 1991-03-11
FR2573080B1 (fr) 1988-11-10
ATE53038T1 (de) 1990-06-15
AU589378B2 (en) 1989-10-12
FI85490B (fi) 1992-01-15
SE8504967D0 (sv) 1985-10-22
US4735936A (en) 1988-04-05
ZA858107B (en) 1986-06-25
NO854212L (no) 1986-04-24
FI82474B (fi) 1990-11-30
GB2169602A (en) 1986-07-16
GB2167298A (en) 1986-05-29
IT1190402B (it) 1988-02-16
IT8522574A0 (it) 1985-10-22
FI88855B (fi) 1993-04-15
GB2167298B (en) 1988-11-02
EP0179440B1 (en) 1990-05-23
NO854213L (no) 1986-04-24
NZ213855A (en) 1989-05-29
GB8526078D0 (en) 1985-11-27
SE8503165D0 (sv) 1985-06-26
FI854127L (fi) 1986-04-24
DK483385D0 (da) 1985-10-22
JPH0515719B2 (ja) 1993-03-02
HUT40674A (en) 1987-01-28
EP0179439A1 (en) 1986-04-30
DK483285A (da) 1986-04-24
FR2573080A1 (fr) 1986-05-16
SE8405295D0 (sv) 1984-10-23
JPS61171422A (ja) 1986-08-02
DE3569188D1 (en) 1989-05-11
AU596080B2 (en) 1990-04-26
IL76777A0 (en) 1986-02-28
SE8503164D0 (sv) 1985-06-26
EP0179441A3 (en) 1988-03-16
FR2571967B1 (fr) 1988-02-05
SE8405295L (sv) 1986-04-24
BE903498A (fr) 1986-02-17
FI88855C (fi) 1993-07-26
SE8503165L (sv) 1986-04-24
IT1190403B (it) 1988-02-16
GB2169602B (en) 1988-10-19
DE3537569A1 (de) 1986-05-22
DE3537542A1 (de) 1986-05-15
SE8504969L (sv) 1986-04-24
NO169010B (no) 1992-01-20
NO169010C (no) 1992-04-29
DK172857B1 (da) 1999-08-16
BE903497A (fr) 1986-02-17
DE3537550A1 (de) 1986-05-15
US4797390A (en) 1989-01-10
FI854127A0 (fi) 1985-10-22
AU582594B2 (en) 1989-04-06
JPS61171491A (ja) 1986-08-02
NO168227C (no) 1992-01-29
EP0179441B1 (en) 1989-04-05
JPH037233B2 (ja) 1991-02-01
AU4893085A (en) 1986-05-01
GB2167283B (en) 1989-05-24
DK172852B1 (da) 1999-08-16
ATE41853T1 (de) 1989-04-15
FI854126A0 (fi) 1985-10-22
CH666812A5 (fr) 1988-08-31
US4734283A (en) 1988-03-29
DE3577851D1 (de) 1990-06-28
US4777134A (en) 1988-10-11
EP0179439B1 (en) 1988-10-12
HU196077B (en) 1988-09-28
ATE37788T1 (de) 1988-10-15
DE3565464D1 (en) 1988-11-17
DK483285D0 (da) 1985-10-22

Similar Documents

Publication Publication Date Title
SE465951B (sv) Isomer av inositoltrifosfat foeretraedesvis i saltform foer anvaendning som terapeutiskt eller profylaktiskt medel samt kompositioner daerav
US5019566A (en) Method of treating inflammation with inositol triphosphate
US5023248A (en) Method of treating diabetes with inositol triphosphate
Zhou et al. Phytic acid in health and disease
Graf et al. Antioxidant functions of phytic acid
CA1337338C (en) Inositoltriphosphate
JPS6133118A (ja) 抗脳性酸素欠乏症代謝賦活剤
US5135923A (en) Method of treating cardiovascular diseases
Gemede Potential health benefits and adverse effects associated with phytate in foods: A review
US5849337A (en) Method of enhancing magnesium absorption and prevention of atherosclerosis
JP4745529B2 (ja) 冷凍スリ身の製造方法
RU2250046C1 (ru) Биологически активная кальцийсодержащая добавка на основе амаранта для восполнения дефицита и нормализации обмена кальция в организме
Marier children and expectant mothers approximately 400 mg/day. According to
Plaut Inosine diphosphatase (nucleoside diphosphatase) from mammalian tissues: 3.6. 1.6 Nucleosiddiphosphate phosphohydrolase
ZAZELENCHUK FACTORS AFFECTING THE AVAILABILITY OF IRON

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8405295-0

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8405295-0

Format of ref document f/p: F